Abundia Global (AGIG) grants director 41,812 options at $2.87

Rhea-AI Filing Summary

Abundia Global Impact Group, Inc. director Matthew T. Henninger reported receiving a stock option grant as compensation for his board service. On January 21, 2026, he was awarded a stock option to buy 41,812 shares of common stock at $2.87 per share, expiring on January 21, 2036. The option vests quarterly over twelve months from the grant date, rather than all at once. The filing notes that he disclaims beneficial ownership of the option and the underlying common shares until they are issued under Abundia’s 2025 Equity Incentive Plan. Following this grant, 41,812 derivative securities (options) are shown as beneficially owned directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Henninger Matthew T.

(Last) (First) (Middle)

C/O ABUNDIA GLOBAL IMPACT GROUP, INC.

1300 POST OAK BLVD., SUITE 1305

(Street)

HOUSTON TX 77056

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ABUNDIA GLOBAL IMPACT GROUP, INC. [ AGIG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/21/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$2.87	01/21/2026		A		41,812(1)		(1)	01/21/2036	Common Stock	41,812	$2.87	41,812	D

Explanation of Responses:

1. Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

	/s/ Matthew T. Henninger	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Abundia Global Impact Group (AGIG) disclose in this Form 4?

The Form 4 reports that director Matthew T. Henninger received a stock option grant as compensation for his services on the board of Abundia Global Impact Group, Inc.

How many stock options did Matthew T. Henninger receive from AGIG and at what exercise price?

He received a stock option for 41,812 shares of Abundia common stock with an exercise price of $2.87 per share, according to the Form 4.

When was the AGIG director stock option granted and when does it expire?

The stock option was granted on January 21, 2026 and carries an expiration date of January 21, 2036, giving a ten-year term from the grant date.

What is the vesting schedule for Matthew T. Henninger’s AGIG stock option?

The filing states that the option’s exercise is subject to quarterly vesting over a period of twelve months from the January 21, 2026 grant date.

Under which plan was the Abundia (AGIG) stock option granted to the director?

The option and the shares issuable upon exercise are tied to Abundia Global Impact Group’s 2025 Equity Incentive Plan, as described in the footnote.

Does the director claim beneficial ownership of the AGIG option and underlying shares?

The footnote explains that the reporting person disclaims beneficial ownership of the option and the common stock issuable upon exercise until issuance under the 2025 Equity Incentive Plan.